Serum uric acid to creatinine ratio and risk of preeclampsia and adverse pregnancy outcomes.
Journal
Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
medline:
7
7
2023
pubmed:
1
6
2023
entrez:
1
6
2023
Statut:
ppublish
Résumé
Preeclampsia is one of the most severe diseases among the hypertensive disorders of pregnancy (HDP) and the leading cause of maternal and fetal morbidity and mortality. It is of crucial importance to early identify women at a high risk for preeclampsia to implement appropriate preventive strategies. In our study, we aimed to test the hypothesis that serum uric acid to creatinine ratio (SUA/sCr) is related to the development of preeclampsia and maternal and neonatal complications. We searched for uric acid and creatine values in the medical records of 269 women who consecutively attended our HDP Clinic from December 2018 to December 2022. We compared the baseline characteristics of participants with normotensive pregnancy ( n = 57), to those with HDP without preeclampsia (HDP-non-PE) ( n = 100) and those with preeclampsia ( n = 112), and we performed adjusted logistic regression analysis to test the associations between SUA/sCr and the development of preeclampsia and maternal and neonatal complications. SUA/sCr was consistently higher in women with preeclampsia in all trimesters of pregnancy. Higher SUA/sCr at the third trimester was associated with an increased odd of developing preeclampsia [odds ratio (OR) 1.29, confidence interval (CI) 1.15-1.50, P = 0.001], preterm birth (OR 1.23, CI 1.05-1.45, P = 0.011), and composite neonatal outcome (OR 1.33, CI 1.12-1.59, P = 0.001), after adjustment for age, BMI before pregnancy, nulliparity, antihypertensive therapy, and acetylsalicylic acid therapy during pregnancy. Having higher SUA/sCr during pregnancy is associated with the development of PE and adverse pregnancy outcomes. Controlled prospective studies are warranted to clarify the predictive power of this novel marker during pregnancy.
Identifiants
pubmed: 37260263
doi: 10.1097/HJH.0000000000003472
pii: 00004872-202308000-00014
pmc: PMC10328517
doi:
Substances chimiques
Uric Acid
268B43MJ25
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1333-1338Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Références
Fantone S, Mazzucchelli R, Giannubilo SR, Ciavattini A, Marzioni D, Tossetta G. AT-rich interactive domain 1A protein expression in normal and pathological pregnancies complicated by preeclampsia. Histochem Cell Biol 2020; 154:339–346.
Opichka MA, Rappelt MW, Gutterman DD, Grobe JL, McIntosh JJ. Vascular dysfunction in preeclampsia. Cells 2021; 10:3055.
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222. Obstet Gynecol 2020; 135:1492–1495.
Stepan H, Hund M, Andraczek T. Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome. Hypertension 2020; 75:918–926.
Stander HJ, Duncan EE, Sisson WE. Chemical studies on the toxemias of pregnancy. Bull Johns Hopkins Hosp 1929; 9:311–326.
Bellos I, Pergialiotis V, Loutradis D, Daskalakis G. The prognostic role of serum uric acid levels in preeclampsia: a meta-analysis. J Clin Hypertens (Greenwich) 2020; 22:826–834.
Borghi C, Piani F. Uric acid and estimate of renal function. Let's stick together. Int J Cardiol 2020; 310:157–158.
Furuhashi M. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity. Am J Physiol Endocrinol Metab 2020; 319:E827–e834.
Qu H, Khalil RA. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia. Am J Physiol Heart Circ Physiol 2020; 319:H661–h681.
Tomimatsu T, Mimura K, Matsuzaki S, Endo M, Kumasawa K, Kimura T. Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors. Int J Mol Sci 2019; 20:4246.
Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002; 106:3073–3078.
San Juan-Reyes S, Gómez-Oliván LM, Islas-Flores H, Dublán-García O. Oxidative stress in pregnancy complicated by preeclampsia. Arch Biochem Biophys 2020; 681:108255.
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43:S14–S31.
Pedersen DC, Bjerregaard LG, Nohr EA, Rasmussen KM, Baker JL. Associations of childhood BMI and change in BMI from childhood to adulthood with risks of hypertensive disorders in pregnancy. Am J Clin Nutr 2020; 112:1180–1187.
Gesuita R, Licini C, Picchiassi E, Tarquini F, Coata G, Fantone S, et al. Association between first trimester plasma htra1 level and subsequent preeclampsia: a possible early marker? Pregnancy Hypertens 2019; 18:58–62.
Harel Z, McArthur E, Hladunewich M, Dirk JS, Wald R, Garg AX, et al. Serum creatinine levels before, during, and after pregnancy. JAMA 2019; 321:205–207.
Lind T, Godfrey KA, Otun H, Philips PR. Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol 1984; 91:128–132.
Fischer RL, Weisberg LS, Hediger ML. Etiology of third-trimester maternal hyperuricemia in nonpreeclamptic twin gestations. Obstet Gynecol 2001; 97:62–65.
Mumford SL, Dasharathy SS, Pollack AZ, Perkins NJ, Mattison DR, Cole SR, et al. Serum uric acid in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. Hum Reprod 2013; 28:1853–1862.
Deepashree PG, Madhushankari GS, Nandini DB, Priya NK, Ashwini R, Shruthy R. Saliva as an alternative noninvasive biomarker for the estimation of uric acid levels during pregnancy: a longitudinal study. J Oral Maxillofac Pathol 2021; 25:457–462.
Koller O. The clinical significance of hemodilution during pregnancy. Obstet Gynecol Surv 1982; 37:649–652.
Troiano NH. Physiologic and hemodynamic changes during pregnancy. AACN Adv Crit Care 2018; 29:273–283.
Gyselaers W. Hemodynamic pathways of gestational hypertension and preeclampsia. Am J Obstet Gynecol 2022; 226:S988–s1005.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39:3165–3241.
Sanchez-Lozada LG, Rodriguez-Iturbe B, Kelley EE, Nakagawa T, Madero M, Feig DI, et al. Uric acid and hypertension: an update with recommendations. Am J Hypertens 2020; 33:583–594.
Piani F, Cicero AFG, Borghi C. Uric acid and hypertension: prognostic role and guide for treatment. J Clin Med 2021; 10:448.
Maloberti A, Biolcati M, Ruzzenenti G, Giani V, Leidi F, Monticelli M, et al. The role of uric acid in acute and chronic coronary syndromes. J Clin Med 2021; 10:4750.
Pecoraro V, Trenti T. Predictive value of serum uric acid levels for adverse maternal and perinatal outcomes in pregnant women with high blood pressure. A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2020; 252:447–454.
Yakiştiran B, Tanaçan A, Altinboğa O, Erol A, Şenel S, Elbayiyev S, et al. Role of derived neutrophil-to-lymphocyte ratio, uric acid-to-creatinine ratio and Delta neutrophil index for predicting neonatal outcomes in pregnancies with preeclampsia. J Obstet Gynaecol 2022; 42:1835–1840.
Vyakaranam S, Bhongir AV, Patlolla D, Chintapally R. Study of serum uric acid and creatinine in hypertensive disorders of pregnancy. Int J Med Sci Public Health 2015; 4:1424–1428.
Yalamati P, Bhongir AV, Betha K, Verma R, Dandge S. Relationship of serum uric acid, serum creatinine and serum cystatin C with maternal and fetal outcomes in rural Indian pregnant women. Int J Reprod Contracept Obstet Gynecol 2015; 4:1505–1510.
Han Q, Zheng S, Chen R, Zhang H, Yan J. A new model for the predicting the risk of preeclampsia in twin pregnancy. Front Physiol 2022; 13:850149.
Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol 2017; 216:110–120. e116.
Magee LA, Smith GN, Bloch C, Côté AM, Jain V, Nerenberg K, et al. Guideline No. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management. J Obstet Gynaecol Can 2022; 44:547–571. e541.
Casiglia E, Tikhonoff V, Virdis A, Grassi G, Angeli F, Barbagallo CM, et al. Serum uric acid /serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values. J Hypertens 2023; 41:180–186.